Blanco Rodríguez C, Pérez-Moneo Agapito B. Evid Pediatr. 2022;18:14
Artículo original: Goenka PK, Hall M, Shah SS, Florin TA, Leone N, Narayanan S, et al. Corticosteroids in the Treatment of Pediatric Retropharyngeal and Parapharyngeal Abscesses. Pediatrics. 2021 Nov;148:e2020037010.
González Rodríguez MP, Flores Villar S. Evid Pediatr. 2021;17:40
Artículo original: Ross RK, Kinlaw AC, Herzog MM, Funk MJ, Gerber JS. Fluoroquinolone Antibiotics and Tendon Injury in Adolescents. Pediatrics. 2021;147:e2020033316.
Ruiz-Canela Cáceres J, Rodríguez-Salinas Pérez E. Evid Pediatr. 2021;17:12
Artículo original: Voysey M, Clemens SAC, Madhi SA, Weckx LY, Folegatti PM, Aley PK, et al. Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK. Lancet. 2021;397:99-111.
Oltra Benavent M, Ochoa Sangrador C. Evid Pediatr. 2020;16:33
Artículo original: Butler CC, van der Velden AW, Bongard E, Saville BR, Holmes J, Coenen S, et al. Oseltamivir plus usual care versus usual care for influenza-like illness in primary care: an open-label, pragmatic, randomised controlled trial. Lancet. 2020;395:42-52.
Ruiz-Canela Cáceres J, García Vera C. Evid Pediatr. 2020;16:26
Artículo original: Nic Lochlainn LM, de Gier B, van der Maas N, van Binnendijk R, Strebel PM, Goodman T, et al. Effect of measles vaccination in infants younger than 9 months on the immune response to subsequent measles vaccine doses: a systematic review and meta-analysis. Lancet Infect Dis. 2019;19:1246-54.
Molina Arias M, Pérez-Moneo Agapito B. Evid Pediatr. 2019;15:45
Artículo original: Malchodi L, Wagner K, Susi A, Gorman G, Hisle-Gorman E. Early acid suppression therapy exposure and fracture in young children. Pediatrics. 2019;144: e20182625.
Molina Arias M, Rivas Fernández MÁ. Evid Pediatr. 2019;15:4
Artículo original:
Goyal V, Grimwood K, Byrnes CA, Morris PS, Masters IB, Ware RS, et al. Amoxicillin-clavulanate versus azithromycin for respiratory exacerbations in children with bronchiectasis (BEST-2): a multicentre, double-blind, non-inferiority, randomized controlled trial. Lancet. 2018;392;1197-206.